ESPEN guidelines on nutrition in acute pancreatitis

Clinical Nutrition

Volumn 21, Issue 2, 2002, Pages 173-183

  Meier, R ^a   Beglinger, C ^b   Layer, P ^c   Gullo, L ^d   Keim, V ^e   Laugier, R ^f   Friess, H ^g   Schweitzer, M ^h   Macfie, J ⁱ  

^a Kantonsspital Liestal   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF HAMBURG   (Germany)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f TIMONE HOSPITAL   (France)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h Klinikum Stadt Hanau   (Germany)

ⁱ SCARBOROUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PANCREAS ENZYME;

ACUTE PANCREATITIS; AMINO ACID METABOLISM; ARTICLE; CARBOHYDRATE METABOLISM; DIET RESTRICTION; DIET THERAPY; DIGESTION; ENTERIC FEEDING; EUROPE; FOOD INTAKE; HUMAN; INTESTINE MOTILITY; INTESTINE TRANSIT TIME; LIPID METABOLISM; MEDICAL SOCIETY; NUTRITIONAL REQUIREMENT; NUTRITIONAL SUPPORT; PANCREAS FUNCTION; PANCREAS SECRETION; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PRACTICE GUIDELINE; PROTEIN METABOLISM; ACUTE DISEASE; CLINICAL PRACTICE; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; METHODOLOGY; PANCREATITIS; STANDARD;

ACUTE DISEASE; HUMANS; NUTRITIONAL SUPPORT; PANCREATITIS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 0036324313     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1054/clnu.2002.0543     Document Type: Article

References (89)

1. Total parenteral nutrition during acute pancreatitis: Clinical experience with 156 patients
2. Luminal digestion of fat
3. Digestion and absorption of carbohydrates and protein
4. Human exocrine pancreatic enzyme secretion
5. Pancreatic secretion
6. Gastric emptying and secretion of bile acids, cholesterol, and pancreatic enzymes during digestion. Duodenal perfusion studies in healthy subjects
7. Different gastric, pancreatic, and biliary responses to solid liquid or homogenized meals
8. Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels
9. Duodenal and ileal nutrient deliveries regulate human intestinal motor and pancreatic responses to a meal
10. Are diets associated with different rates of human interdigestive and postprandial pancreatic enzyme secretion?
11. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules
12. Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans
13. Role of nonpancreatic lipolytic activity in exocrine pancreatic insufficiency
14. Nutrients and cyclical interdigestive pancreatic enzyme secretion in humans
15. Fate of pancreatic enzymes during small intestinal aboral transit in humans
16. Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans
17. Survival of human pancreatic enzymes during small bowel transit: Effect of nutrients, bile acids, and enzymes
18. Incomplete absorption of the carbohydrate in all-purpose wheat flour
19. Control of human postprandial pancreatic exocrine secretion: A function of the gastroduodenal region
20. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion
21. Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans
22. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man
23. Human pancreatic secretion and intestinal motility: Effects of ileal nutrient perfusion
24. Altered postprandial motility in chronic pancreatitis: Role of malabsorption
25. Evidence for hormonal inhibition of exocrine pancreatic function by somatostatin 28 in humans
26. Inhibition of pancreas and gallbladder by pancreatic polypeptide
27. Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes
28. Human pancreatic secretion during phase II antral motility of the interdigestive cycle
29. Cholinergic regulation of phase II interdigestive pancreatic secretion in humans
30. Relationships among canine fasting pancreatic and biliary secretions pancreatic duct pressure and duodenal phase III motor activity
31. Relationship of diagnostic serum amylase to aetiology and prognosis in acute pancreatitis
32. A clinically based classification system for acute pancreatitis
33. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: A multicentre study
34. Prognostic signs and the role of operative management in acute pancreatitis
35. Acute pancreatitis: Prognostic value of CT
36. Glucose, fatty acid, and urea kinetics in patients with severe pancreatitis. The response to substrate infusion and total parenteral nutrition
37. Resting energy expenditure in patients with pancreatitis
38. Energy expenditure during severe acute pancreatitis
39. Changing methods in the treatment of severe pancreatitis
40. Total parenteral nutrition and alternate energy substrates in treatment of severe acute pancreatitis
41. Nutrition support in clinical practice: Review of published data and recommendations for future research directions
42. The safety and efficacy of a lipid-based system of parenteral nutrition in acute pancreatitis
43. Acute pancreatitis with hyperlipemia. Evidence for a persistent defect in lipid metabolism
44. Hyperlipoproteinemia and pancreatitis
45. Pancreatic enzyme secretion during intravenous fat infusion
46. Pancreatic protein secretion and gastrointestinal hormone release in response to parenteral amino acids and lipid in dogs
47. Intravenous amino acids and fat stimulate pancreatic secretion
48. Intravenous mixed amino acids and fats do not stimulate exocrine pancreatic secretion
49. Intravenous versus intraduodenal amino acids, fats, and glucose as stimulants of pancreatic secretion
50. Effect of intravenous lipid on human pancreatic secretion
51. Pancreatitis and hyperlipidemia
52. Acute pancreatitis with hyperlipemia: The incidence of lipid abnormalities in acute pancreatitis
53. Pathogenesis and treatment of pancreatitis due to essential fatty acid deficiency
54. The therapy of acute pancreatitis through intravenous hyperalimantation with fat emulsions
55. A controlled study on the use of intravenous fat in patients suffering from acute attacks of pancreatitis
56. Pancreatitis induced by intravenous infusion of a fat emulsion in an alcoholic patient
57. Acute pancreatitis associated with high-concentration lipid emulsion during total parenteral nutrition therapy for Crohn's disease
58. Pancreatitis and intravenous fat: An association in patients with inflammatory bowel disease
59. Clinical nutrition in pancreatitis
60. Pancreatic enzyme response with an elemental diet
61. Effect of elemental diet on pancreatic secretion
62. Rat pancreatic secretory response to intraduodenal infusion of elemental vs polymeric defined-formula diet
63. Pancreatic secretion in response to jejunal feeding of elemental diet
64. Effect of enteral nutrition on human pancreatic secretions
65. Effect of continuous jejunal perfusion of elemental and complex nutritional solutions on pancreatic enzyme secretion in human subjects
66. Intrajejunal administration of an elemental diet at neutral pH avoids pancreatic stimulation. Studies in dog and man
67. Effect of parenteral amino acids on human pancreatic exocrine secretion
68. Effects of intravenous infusion of amino acids, fat, or glucose on unstimulated pancreatic secretion in healthy humans
69. Effects of total parenteral nutrition on exocrine pancreatic secretion
70. Effect of acute hyperglycemia on basal and cholecystokinin-stimulated exocrine pancreatic secretion in humans
71. Comparison of the safety of early enteral vs parenteral nutrition in mild acute pancreatitis
72. Benefits and complications of parenteral nutritional support
73. Enteral versus parenteral nutrition: The significance of bacterial translocation and gut-barrier function
74. Immediate metabolic effects of different nutritional regimens in critically ill patients
75. Early total parenteral nutrition in acute pancreatitis: Lack of beneficial effects
76. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
77. Role of the gut in multiple organ failure: Bacterial translocation and permeability changes
78. Influence of postoperative entral nutrition on postsurgical infections
79. Enteral nutrition prevents bacterial translocation but does not improve survival during acute pancreatitis
80. Complications and costs of early postoperative parenteral versus enteral nutrition in trauma patients
81. Should immunonutrition become routine in critically ill patiens? A systematic review of the evidence
82. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis
83. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: Results of a randomized prospective trial
84. Randomized controlled trial of the effect of early enteral nutrition on markers of the inflammatory response in predicted severe acute pancreatitis
85. Enteral versus parenteral nutrition: A pragmatic study
86. Frequency and risk factors of recurrent pain during refeeding in patients with acute pancreatitis: A multivariate multicentre prospective study of 116 patients
87. Early tube feeding in acute pancreatitis: A prospective study
88. Postoperative jejunal feedings following complicated pancreatitis
89. Is early enteral nutrition in acute pancreatitis dangerous? About 20 patients fed by an endoscopically placed nasogastrojejunal tube